CYP2C19 and Nongenetic Factors Predict Poor Responsiveness to Clopidogrel Loading dose after Coronary Stent Implantation

  • Tobias Geisler
    Department of Cardiology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, Tuebingen, Germany. Tel.: Fax:
  • Elke Schaeffeler
    Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Auerbachstrasse 112 Germany. Tel.: Fax:
  • Juergen Dippon
    Department of Mathematics, University of Stuttgart, Stuttgart, Germany
  • Stefan Winter
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Verena Buse
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Christian Bischofs
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Christine Zuern
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Klaus Moerike
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Meinrad Gawaz
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  • Matthias Schwab
    Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany

Journal

  • Pharmacogenomics

    Pharmacogenomics 9 (9), 1251-1259, 2008-09

    Informa UK Limited

Citations (3)*help

See more

Details 詳細情報について

Report a problem

Back to top